Rudnick Michael R, Goldfarb Stanley
Division of Nephrology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Rev Cardiovasc Med. 2003;4 Suppl 5:S28-33.
Experimental studies suggest that the pathogenesis of contrast media nephrotopathy is due to a combination of renal ischemia and direct tubular epithelial cell toxicity. Clinical studies to date have demonstrated a reduction in clinical contrast nephropathy with the introduction of low-osmolar and, more recently, iso-osmolar contrast media. Numerous experimental studies have examined the role of osmolality per se in the pathogenesis of contrast nephropathy, with conflicting results. Whether iso-osmolar contrast media are the least nephrotoxic iodinated contrast media needs to be determined with large prospective randomized clinical trials.
实验研究表明,造影剂肾病的发病机制是肾缺血和肾小管上皮细胞直接毒性共同作用的结果。迄今为止的临床研究表明,低渗造影剂的引入,以及最近等渗造影剂的应用,已使临床造影剂肾病的发生率有所降低。众多实验研究探讨了渗透压本身在造影剂肾病发病机制中的作用,但结果相互矛盾。等渗造影剂是否是肾毒性最小的含碘造影剂,需要通过大规模前瞻性随机临床试验来确定。